ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 35 filers reported holding ESSA PHARMA INC in Q3 2023. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $461 | +6.2% | 149,143 | -7.2% | 0.00% | +100.0% |
| Q2 2023 | $434 | -30.0% | 160,643 | -23.1% | 0.00% | -50.0% |
| Q1 2023 | $620 | +48.7% | 208,791 | +26.1% | 0.00% | +100.0% |
| Q4 2022 | $417 | -99.7% | 165,641 | +114.5% | 0.00% | 0.0% |
| Q3 2022 | $141,000 | -52.7% | 77,236 | -18.3% | 0.00% | 0.0% |
| Q2 2022 | $298,000 | -58.1% | 94,578 | -17.9% | 0.00% | -50.0% |
| Q1 2022 | $712,000 | -40.5% | 115,232 | +36.8% | 0.00% | -33.3% |
| Q4 2021 | $1,196,000 | +896.7% | 84,230 | +738.1% | 0.00% | – |
| Q4 2020 | $120,000 | +73.9% | 10,050 | 0.0% | 0.00% | – |
| Q3 2020 | $69,000 | +11.3% | 10,050 | 0.0% | 0.00% | – |
| Q2 2020 | $62,000 | +55.0% | 10,050 | 0.0% | 0.00% | – |
| Q1 2020 | $40,000 | -27.3% | 10,050 | 0.0% | 0.00% | – |
| Q4 2019 | $55,000 | +61.8% | 10,050 | 0.0% | 0.00% | – |
| Q3 2019 | $34,000 | +36.0% | 10,050 | 0.0% | 0.00% | – |
| Q2 2019 | $25,000 | -26.5% | 10,050 | 0.0% | 0.00% | – |
| Q1 2019 | $34,000 | +61.9% | 10,050 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -30.0% | 10,050 | 0.0% | 0.00% | – |
| Q3 2018 | $30,000 | -21.1% | 10,050 | 0.0% | 0.00% | – |
| Q2 2018 | $38,000 | – | 10,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
| MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
| BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
| Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
| Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
| Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
| Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
| RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
| Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |